A comparison between Chek 2 mutation carriers and non carriers in early breast cancer patients: A clinicopathological analysis

被引:0
|
作者
Huszno, J. [1 ]
Budryk, M. [2 ,3 ]
Tecza, K. [2 ,4 ]
Pilat, J. Pamula [2 ,4 ]
Grzybowska, E. [2 ,4 ]
Kolosza, Z. [2 ,5 ,6 ]
Nowara, E. [1 ]
机构
[1] Maria Sklodowska Curie Mem Inst Oncol, Clin & Expt Oncol Dept, Gliwice, Poland
[2] MSC Mem Canc Centere, Gliwice, Poland
[3] Inst Oncol, Gliwice Branch, Genet Outpationt Clin, Gliwice, Poland
[4] Inst Oncol, Gliwice Branch, Ctr Translat Res & Mol Biol Canc, Gliwice, Poland
[5] Inst Oncol, Gliwice Branch, Dept Epidemiol, Gliwice, Poland
[6] Silesia Canc Registry, Gliwice, Poland
关键词
D O I
10.1016/S0959-8049(16)30139-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
253
引用
收藏
页码:S44 / S44
页数:1
相关论文
共 50 条
  • [31] AIB1 polymorphisms with breast cancer susceptibility: a pooled analysis of variation in BRCA1/2 mutation carriers and non–carriers
    Ying Zhang
    Meiyan Huang
    Zhenglan Zhu
    Molecular Biology Reports, 2012, 39 : 6881 - 6886
  • [32] Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study
    Mellemkjaer, L.
    Dahl, C.
    Olsen, J. H.
    Bertelsen, L.
    Guldberg, P.
    Christensen, J.
    Borresen-Dale, A-L
    Stovall, M.
    Langholz, B.
    Bernstein, L.
    Lynch, C. F.
    Malone, K. E.
    Haile, R. W.
    Andersson, M.
    Thomas, D. C.
    Concannon, P.
    Capanu, M.
    Boice, J. D., Jr.
    Bernstein, J. L.
    BRITISH JOURNAL OF CANCER, 2008, 98 (04) : 728 - 733
  • [33] Survival of breast cancer in BRCA1 and BRCA2 carriers versus non-carriers: mutation analysis and tumour characteristics
    Schmidt, M. K.
    Tollenaar, R. A. E. M.
    van Leeuwen, F. E.
    van't Veer, L. J.
    EJC SUPPLEMENTS, 2004, 2 (03): : 152 - 152
  • [34] Hormone replacement therapy, oral contraceptives, and reproductive history in Jewish Israeli breast cancer patients: comparison of BRCA1/2 mutation carriers with non-carriers.
    Bar Sade, RB
    Chetrit, A
    Figer, A
    Papa, M
    Flex, D
    Riezel, S
    Friedman, E
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 233 - 233
  • [35] A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers
    Thompson, Deborah
    Seal, Sheila
    Schutte, Mieke
    McGuffog, Lesley
    Barfoot, Rita
    Renwick, Anthony
    Eeles, Rosalind
    Sodha, Nayanta
    Houlston, Richard
    Shanley, Susan
    Klijn, Jan
    Wasielewski, Marijke
    Chang-Claude, Jenny
    Futreal, P. Andrew
    Weber, Barbara L.
    Nathanson, Katherine L.
    Stratton, Michael
    Meijers-Heijboer, Hanne
    Rahman, Nazneen
    Easton, Douglas F.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (12) : 2542 - 2545
  • [36] Patterns of Surgery in Non-BRCA Mutation Carriers with Breast Cancer
    Karzai, Shkala
    Port, Elisa
    Schmidt, Hank
    Cate, Sarah
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S592 - S593
  • [37] Breast cancer surveillance for BRCA1/2 mutation carriers - is "early detection" early enough?
    Bernstein-Molho, Rinat
    Kaufman, Bella
    Ben David, Merav A.
    Sklair-Levy, Miri
    Feldman, Dana Madoursky
    Zippel, Dov
    Laitman, Yael
    Friedman, Eitan
    BREAST, 2020, 49 : 81 - 86
  • [38] AIB1 polymorphisms with breast cancer susceptibility: a pooled analysis of variation in BRCA1/2 mutation carriers and non-carriers
    Zhang, Ying
    Huang, Meiyan
    Zhu, Zhenglan
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (06) : 6881 - 6886
  • [39] The landscape of somatic genetic alterations in breast cancers from CHEK2 germline mutation carriers
    Kumar, R.
    Pei, X.
    Selenica, P.
    Wen, H. Y.
    Powell, S.
    Robson, M.
    Riaz, N.
    Reis-Filho, J. S.
    Weigelt, B.
    Mandelker, D.
    CANCER RESEARCH, 2019, 79 (04)
  • [40] Sensitivity to first-line chemotherapy for metastatic breast cancer in CHEK2 1100delC mutation carriers is not different compared with sporadic breast cancer patients
    Kriege, M.
    Jager, A.
    Hollestelle, A.
    Berns, P. M. J. J.
    Sieuwerts, A. M.
    Collee, J. M.
    Kroep, J. R.
    Martens, J. W. M.
    Hooning, M. J.
    Seynaeve, C.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S107 - S108